Innovative Biotherapies Inc is categorized under Commercial Biotechnical Research in Ann Arbor, MI and active since 2003.
Innovative Biotherapies Inc was established in 2003, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact H David Humes at the company’s single location by writing to 650 Avis Drive 300, Ann Arbor, Michigan MI 48108 or by phoning (734) 997-7055. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Innovative Biotherapies Inc |
| Contact Person: | H David Humes |
| Address: | 650 Avis Drive 300, Ann Arbor, Michigan 48108 |
| Phone Number: | (734) 997-7055 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Innovative Biotherapies Inc was started in 2003 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact H David Humes for inquiries that concern Innovative Biotherapies Inc by calling the company number (734) 997-7055, as your correspondence is most welcome. Additionally, the physical location of the single location of Innovative Biotherapies Inc can be found at the coordinates 42.212393,-83.740521 as well as the street address 650 Avis Drive 300 in Ann Arbor, Michigan 48108.
For its online presence, you may visit Innovative Biotherapies Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.